Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nexelis provides advanced laboratory and bioanalytical testing services supporting preclinical through Phase I-IV clinical studies for pharmaceutical and biotech companies. Their work has supported the FDA filing of nearly 350 new molecular entities including blockbuster vaccines, biologics, anti-virus drugs, immunotherapies, gene therapies and cell therapies. They are recognized for expertise in immunology assays and biomarker development with CAP/CLIA/GLP/GCP certifications at several global sites.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nexelis.